Table 2:
Median serum concentration of analyzed chemokines in AD patients (Group 1 and Group 2) and Controls (Control 1 and 2).
Protein
Median concentration pg/mL (upper/lower quartile)
Median concentration pg/mL (upper/lower quartile)
Mdian concentration pg/mL (upper/lower quartile)
Median concentration pg/mL (upper/lower quartile)
𝑃
(statistically significant)
Group 1 (1)
𝑛
=
2
3
Control 1 (2)
𝑛
=
3
0
Group 2 (3)
𝑛
=
1
7
Control 2 (4)
𝑛
=
2
0
CXCL-9
56.7 (29.8/75.1)
87.3 (55.4/132.0)
34.1 (23.9/62.9)
17.9 (12.5/26.7)
𝑃
1
−
2
=
.
0
0
3
𝑃
2
−
4
=
.
0
0
0
0
4
CXCL-10
84.8 (60.8/94.3)
98.0 (76.4/135.2)
93.6 (67.4/114.9)
75.8 (63.2/112.5)
𝑃
1
−
2
=
.
0
4
CXCL-11
52.9 (36.1/64.6)
66.9 (40.8/135.2)
57.4 (45.5/97.6)
43.2 (36.1/57.4)
𝑃
2
−
4
=
.
0
4
9
CXCL-12
2444.9 (2291.2/2711)
2135.8 (1821.4/2364.7)
2553.5 (2393.9/2618.2)
2361.1 (2239.5/2430.3)
𝑃
1
−
2
=
.
0
0
4
𝑃
3
−
4
=
.
0
1
CCL-17
405.2 (294.4/729.9)
620.1 (369.9/889.2)
357.6 (257.4/547.3)
178.3 (132.8/304.9)
𝑃
1
−
2
=
.
0
4
𝑃
2
−
4
=
.
0
0
1
𝑃
3
−
4
=
.
0
4
CCL-20
7.8 (7.6/13.1)
8.3 (7.8/35.1)
7.4 (7.1/7.9)
6.9 (5.9/7.8)
𝑃
1
−
3
=
.
0
3
𝑃
2
−
4
=
.
0
0
8
CCL-21
158.1 (108.8/234.9)
175.5 (85.5/243.3)
158.1 (126.9/209.8)
160.7 (140.4/188.4)
𝑃
<
.
0
5
for all comparisons
CCL-22
1147.5 (908.6/1395.3)
1410.2 (1010.5/1612.8)
1152.5 (945.3/1390.5)
606.1 (571.3/726.1)
𝑃
2
−
4
=
.
0
0
0
0
3
𝑃
3
−
4
=
.
0
0
1
CCL-27
463.5 (406.1/519.6)
406.6 (326.8/452.9)
487.1 (367.1/628.3)
385.0 (342.7/544.3)
𝑃
1
−
2
=
.
0
3
IL-18
64.8 (54.1/73.1)
94.7 (80.6/124.9)
63.3 (56.9/83.7)
77.2 (60.4/96.3)
𝑃
1
−
2
=
.
0
0
0
1
𝑃
2
−
4
=
.
0
4
9